Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $557.50 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $150.00 | 1 | $0 (2017) |
| Team_Makena_LLC | $134.85 | 3 | $0 (2021) |
| Amgen Inc. | $134.57 | 2 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $56.02 | 4 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $28.81 | 1 | $0 (2017) |
| Smith+Nephew, Inc. | $18.66 | 1 | $0 (2021) |
| DePuy Synthes Sales Inc. | $17.76 | 1 | $0 (2023) |
| KCI USA, Inc. | $16.83 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.76 | 1 | DePuy Synthes Sales Inc. ($17.76) |
| 2021 | $53.44 | 3 | Smith+Nephew, Inc. ($18.66) |
| 2020 | $77.94 | 1 | Team_Makena_LLC ($77.94) |
| 2019 | $43.35 | 3 | Ferring Pharmaceuticals Inc. ($43.35) |
| 2018 | $38.96 | 1 | Team_Makena_LLC ($38.96) |
| 2017 | $326.05 | 5 | Stryker Corporation ($150.00) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2023 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Sports Early Intervention | ||||||
| 11/11/2021 | KCI USA, Inc. | PREVENA (Device) | Food and Beverage | Cash or cash equivalent | $16.83 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 11/02/2021 | Smith+Nephew, Inc. | FAST-FIX FLEX (Device), NOVOSTITCH PRO | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Sports Med Knee | ||||||
| 03/02/2021 | Team_Makena_LLC | — | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| 09/29/2020 | Team_Makena_LLC | — | Food and Beverage | Cash or cash equivalent | $77.94 | General |
| 08/15/2019 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: ORTHOPEDICS | ||||||
| 06/07/2019 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: ORTHOPEDICS | ||||||
| 01/31/2019 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ORTHOPEDICS | ||||||
| 10/04/2018 | Team_Makena_LLC | — | Food and Beverage | Cash or cash equivalent | $38.96 | General |
| 03/21/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $112.47 | General |
| Category: Endocrinology | ||||||
| 03/16/2017 | Stryker Corporation | Makoplasty (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: KNEES, HIPS | ||||||
| 03/07/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Endocrinology | ||||||
| 01/12/2017 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: ORTHOPEDICS | ||||||
| 01/05/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device), SYNVISC-ONE | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: OSTEOARTHRITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 295 | 491 | $111,792 | $30,873 |
| 2022 | 10 | 381 | 608 | $151,828 | $42,317 |
| 2021 | 8 | 299 | 480 | $108,887 | $29,529 |
| 2020 | 7 | 290 | 381 | $83,518 | $22,048 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 235 | $62,980 | $17,105 | 27.2% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 13 | 37 | $12,164 | $3,627 | 29.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $13,240 | $3,432 | 25.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 30 | $6,369 | $1,898 | 29.8% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 33 | 43 | $4,687 | $1,334 | 28.5% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2023 | 16 | 36 | $4,212 | $1,217 | 28.9% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 25 | 33 | $4,224 | $1,149 | 27.2% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 15 | 16 | $2,016 | $562.86 | 27.9% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 20 | 21 | $1,900 | $548.05 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 270 | $72,900 | $20,369 | 27.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 70 | 70 | $23,240 | $6,169 | 26.5% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2022 | 18 | 58 | $21,576 | $5,990 | 27.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 20 | 45 | $15,704 | $4,724 | 30.1% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 38 | 44 | $4,769 | $1,361 | 28.5% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 30 | 33 | $4,290 | $1,138 | 26.5% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2022 | 21 | 31 | $3,627 | $978.28 | 27.0% |
| 73560 | X-ray of knee, 1-2 views | Office | 2022 | 26 | 26 | $2,184 | $581.55 | 26.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 15 | 15 | $1,890 | $565.09 | 29.9% |
| 73080 | X-ray of elbow, minimum of 3 views | Office | 2022 | 11 | 16 | $1,648 | $441.52 | 26.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 112 | 242 | $67,399 | $18,473 | 27.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 64 | 64 | $21,778 | $5,555 | 25.5% |
| 73562 | X-ray of knee, 3 views | Office | 2021 | 31 | 40 | $5,200 | $1,424 | 27.4% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2021 | 30 | 43 | $4,688 | $1,223 | 26.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2021 | 14 | 31 | $3,392 | $966.52 | 28.5% |
| 73560 | X-ray of knee, 1 or 2 views | Office | 2021 | 25 | 28 | $2,555 | $751.45 | 29.4% |
About Dr. Robert Fields, M.D
Dr. Robert Fields, M.D is a Sports Medicine healthcare provider based in West Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568465334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Fields, M.D has received a total of $557.50 in payments from pharmaceutical and medical device companies, with $17.76 received in 2023. These payments were reported across 14 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($557.50).
As a Medicare-enrolled provider, Fields has provided services to 1,265 Medicare beneficiaries, totaling 1,960 services with total Medicare billing of $124,768. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location West Hills, CA
- Active Since 05/24/2005
- Last Updated 06/01/2021
- Taxonomy Code 207XX0005X
- Entity Type Individual
- NPI Number 1568465334
Products in Payments
- Makoplasty (Device) $150.00
- Prolia (Biological) $134.57
- EUFLEXXA (Device) $56.02
- SYNVISC-ONE (Device) $28.81
- FAST-FIX FLEX (Device) $18.66
- ORTHOVISC (Device) $17.76
- PREVENA (Device) $16.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.